Opendata, web and dolomites

TransPot SIGNED

Translational Research Network in Prostate Cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "TransPot" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF GLASGOW 

Organization address
address: UNIVERSITY AVENUE
city: GLASGOW
postcode: G12 8QQ
website: www.gla.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.beatson.gla.ac.uk/TransPot/transpot.html
 Total cost 2˙629˙315 €
 EC max contribution 2˙629˙315 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2016
 Funding Scheme MSCA-ITN-ETN
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF GLASGOW UK (GLASGOW) coordinator 273˙287.00
2    GenomeScan B.V. NL (Leiden) participant 319˙217.00
3    ALMAC DIAGNOSTIC SERVICES LIMITED UK (CRAIGAVON) participant 273˙287.00
4    UNIVERSITY OF NEWCASTLE UPON TYNE UK (NEWCASTLE UPON TYNE) participant 273˙287.00
5    TAMPEREEN KORKEAKOULUSAATIO SR FI (TAMPERE) participant 269˙145.00
6    TURUN YLIOPISTO FI (Turku) participant 269˙145.00
7    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL (ROTTERDAM) participant 255˙374.00
8    NUMARES AG DE (REGENSBURG) participant 249˙216.00
9    IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON EL (ATHINA) participant 242˙386.00
10    THE QUEEN'S UNIVERSITY OF BELFAST UK (BELFAST) participant 204˙965.00
11    MOSAIQUES DIAGNOSTICS GMBH DE (HANNOVER) participant 0.00
12    TAMPEREEN YLIOPISTO FI (TAMPERE) participant 0.00
13    CANCER RESEARCH UK LBG UK (LONDON) partner 0.00
14    Carver Wilde Communications UK (London) partner 0.00
15    European Association of Urology CH (Bern) partner 0.00
16    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) partner 0.00
17    Prostate Cancer UK UK (London) partner 0.00
18    UNIVERSITY OF STRATHCLYDE UK (GLASGOW) partner 0.00

Map

 Project objective

The Translational Research Network for Prostate Cancer (TransPot) program adopts an innovative, multidisciplinary approach, providing highly sought-after, effective solutions for incurable prostate cancer (PC).

The TransPot scientific objective is to obtain an unmatched depth of molecular, mechanistic and informatics systems-level disease understanding in order to improve the prognosis and treatment of lethal PC, aimed to (i) provide important insights into molecular mechanisms driving treatment resistant PC including castrate-resistant PC (CRPC), (ii) identify novel therapeutic targets, (iii) develop and validate predictive models for disease progression, prognosis and responsiveness to current and novel (co-)treatment options, and (iv) provide superior, clinically relevant tools and biomarker signatures for personalising and optimising CRPC therapy. Our research program is built on network-wide, state-of-the-art cancer biology-based mechanistic research integrated with a systems medicine approach: 1. Cancer biology-based mechanistic research incorporating a comprehensive range of model systems incorporating unique, pre-clinical and clinical resources and distinct phenotypic high content screen platforms. 2. A systems medicine approach with mathematical modelling to develop novel predictive/prognostic tools. 3. Centres of excellence in surgery, oncology and clinical trials, comprising clinical infrastructure and essential resources whereby candidate therapeutic targets and predictive/prognostic tools can be comprehensively evaluated, including accessing bio-repository resources. We will train young scientists to apply multiple ‘omics’ technologies and approaches in model systems and systems biology to answer important clinically-relevant questions. Advances achieved will facilitate personalized targeted-medicine in treating lethal PC, and will impact beyond the scientific community by improving the well-being of advanced PC patients.

 Deliverables

List of deliverables.
ESRs Recruitment Other 2020-04-15 09:09:56
TransPot website and social media presence built, maintained and operated Websites, patent fillings, videos etc. 2020-04-15 09:09:56
PCDP and researcher declarations Other 2020-04-15 09:09:56

Take a look to the deliverables list in detail:  detailed list of TransPot deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Marouane Kdadra, Sebastian Höckner, Hing Leung, Werner Kremer, Eric Schiffer
Metabolomics Biomarkers of Prostate Cancer: A Systematic Review
published pages: 21, ISSN: 2075-4418, DOI: 10.3390/diagnostics9010021
Diagnostics 9/1 2020-04-15
2018 S. Umbreen, R.E. Steele, N. Poulose, S. Mcdade, N. Mccabe, I.G. Mills
Approaches to enrich for androgen receptor binding sites in low-cell number samples
published pages: e2499, ISSN: 1569-9056, DOI: 10.1016/s1569-9056(18)32982-8
European Urology Supplements 17/10 2020-04-15
2018 P. Singh, C.N. Robson, R. Heer
In vitro prostate differentiation of induced pluripotent stem cells and organoid generation using seminal vesicle mesenchyme
published pages: e2557, ISSN: 1569-9056, DOI: 10.1016/s1569-9056(18)33034-3
European Urology Supplements 17/10 2020-04-15

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRANSPOT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TRANSPOT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SuperCol (2020)

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Read More  

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

INSPIRE (2019)

INNOVATIVE GROUND INTERFACE CONCEPTS FOR STRUCTURE PROTECTION

Read More